Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/jmv.26100

http://scihub22266oqcxt.onion/10.1002/jmv.26100
suck pdf from google scholar
32472706!7300755!32472706
unlimited free pdf from europmc32472706    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32472706      J+Med+Virol 2020 ; 92 (11): 2429-2439
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The long-standing history of Corynebacterium parvum, immunity, and viruses #MMPMID32472706
  • Palmieri B; Vadala M; Roncati L; Garelli A; Scandone F; Bondi M; Cermelli C
  • J Med Virol 2020[Nov]; 92 (11): 2429-2439 PMID32472706show ga
  • We report a review of all the experimental and clinical studies performed in the last 60 years on the antiviral activity of inactivated Corynebacterium parvum (Cutibacterium acnes). This bacterium has been originally investigated and used for its oncolytic properties linked to immunomodulating activity, but the interest to successfully prevent and treat bacterial, fungal, and viral infections and lethality, uprising the innate immunity barriers produced many experimental models and very few clinical studies. The dramatic defenseless situation due to impending CoViD-19 pandemic claims to exhume and highlight this aspecific strategy in preventive and therapeutic settings; as a matter of fact, no new or mutated virus can potentially escape to this strong innate immune surveillance strengthened by adequate C. parvum protocols.
  • |*Immunity, Innate[MESH]
  • |*Immunologic Surveillance[MESH]
  • |Animals[MESH]
  • |COVID-19/prevention & control[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Humans[MESH]
  • |Immunologic Factors/*administration & dosage/therapeutic use[MESH]
  • |Propionibacterium acnes/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box